2[3]Kohorn EI, Goldstein DP, Hancock BW, et al. Combining the staging system of the international federation of gynecology and obstetrics with the scoring system of the world health organization for trophoblastic neoplasia. Report of the working committee of the international society for the study of trophoblastic disease and the international gynecologic cancer society. Int J Gynecol Cancer, 2000, 10:84 - 88
3[4]Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment. Int J Gynecol Cancer, 2001, 11:73-77
4[6]Newlands ES, Bagshawe KD, Begent RHJ, et al. Results with EMA/CO (etopside, methotrexate, actinomycin, cyclophosphamide and vincristine) regimen in high risk gestational trophoblastic tumours, 1970 to 1989.Br.J Obstet Gynecol, 1991, 98:550-557
5[7]Soper JT, Evans AC, Clarke- Pearson D, et al. Alternating weekly chemotherapy with etopside - methotrexate - dactinomycin/cyclophosphmide vincristine for high- risk gestational trophoblastic disease. Obstet Gynecol, 1994, 83: 113-117
6[8]Newlands ES, Mulholland PJ, Holden L, et al. Etoposide and cisplatin/ etoposide, methotrexate, and actinomycine D (EMA)chemotherapy for patients with high - risk gestational trophoblastic tumouts refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumours. J Clin Oncol, 2000, 18:854-859
7[9]Van Besien K, Verschraegen C, Mehra R, et al. Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue. Gynecol Oncol, 1997, 65:366-369
8[10]Lehman E, Gershenson DM, Burke TW, et al. Salvage surgery for che morefractory gestational trophoblastic disease. J Clin Oncol, 1994, 12: 2737 - 2747
9[11]Wojtowitz- Praga S, Tord J, Johnson M, et al. Phase I trial ma rimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. J Clin Oncol, 1998, 16: 2150 - 2156
